Replies to post #6839 on Provectus Biopharmaceuticals Inc (PVCT)

[236T568]

You don't see the problem?

come back when the price in the private placements drops from $1.00 to .80 to .60 to .50 then to .20 and below

how many shares will be issued?

then you have to factor in the value of the massive amount of warrants that will be issued as an incentive in order to get investors to invest in PVCT

this just does not look good

Now if you factor that 70% of the cost of testing is in PIII then one could expect to spend at least 700 million for PIII. However, PVCT expects to spend less than 20 million over two years. I don't see the problem.